{
  "abstract": "OBJECTIVES: We aimed to estimate whether adding oral glucocorticoids to ILD-modifying therapy improves 12-month lung outcomes in systemic sclerosis-associated interstitial lung disease (SSc-ILD). METHODS: We emulated a target trial using the EUSTAR database. Eligible adults with confirmed SSc-ILD initiated an eligible ILD-modifying therapy at baseline (T0), either alone or with oral glucocorticoids added (prednisone-equivalent dose ≤20 mg/day). Follow-up ended at the visit closest to 12 months within a 9 to 15-month window. The primary outcome was the between-group difference in change in FVC (% predicted). Secondary outcomes were progressive lung fibrosis and isolated DLCO decline ≥15%. We used multiple imputation (m=80), stabilised inverse probability of treatment weighting, robust variance estimators and Rubin's rules. RESULTS: Of 443 patients, 185 (41.8%) received oral glucocorticoids with ILD-modifying therapy and 258 (58.2%) received ILD-modifying therapy alone. Adding oral glucocorticoids was not associated with improved 12-month FVC. The adjusted mean difference in FVC change was -2.10 percentage points (95% CI -4.68 to 0.47; p=0.11). There was no clear difference in progressive lung fibrosis (RR 1.40, 95% CI 0.83 to 2.35) or isolated DLCO decline ≥15% (RR 0.81, 95% CI 0.39 to 1.69). Findings were consistent in the truncated-weight sensitivity analysis. CONCLUSION: Adding oral glucocorticoids to ILD-modifying therapy was not associated with improved 12-month FVC in SSc-ILD. Secondary outcomes were sparse and should be interpreted cautiously.",
  "abstract_shown": true,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 14,
  "authors": [
    {
      "name": "Zubeyir Salis"
    },
    {
      "name": "Simona Truglia"
    },
    {
      "name": "Oliver Distler"
    },
    {
      "name": "Gábor Kumánovics"
    },
    {
      "name": "Gianluca Moroncini"
    },
    {
      "name": "David Launay"
    },
    {
      "name": "Silvia Bellando-Randone"
    },
    {
      "name": "Gonçalo Boleto"
    },
    {
      "name": "Nicoletta del Papa"
    },
    {
      "name": "Ana Maria Gheorghiu"
    },
    {
      "name": "Duygu Temiz Karadag"
    },
    {
      "name": "Zguro Batalov"
    },
    {
      "name": "Gabriella Szucs"
    },
    {
      "name": "Michele Iudici"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/bd0fmvs2et607.bib",
  "cited_by": 0,
  "doi": "10.1002/acr.80205",
  "fulltext_url": null,
  "id": "bd0fmvs2et607",
  "issns": [
    "2151-464X",
    "2151-4658"
  ],
  "landing_url": "https://hal.science/hal-05864436v1",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "hal",
      "0.sdv"
    ],
    [
      "openalex",
      "2745|Systemic Sclerosis and Related Diseases"
    ]
  ],
  "openalex": "W7225848216",
  "pdf_url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr.80205",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-11",
  "publisher": "American College of Rhumatology",
  "ris": "https://research.draconitic.com/paper/bd0fmvs2et607.ris",
  "sources": [
    {
      "first_seen": "2026-11-14T12:20:48Z",
      "native_id": "hal-05864436",
      "source": "hal",
      "url": "https://hal.science/hal-05864436v1"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "hal:0.sdv",
      "subfield": "general"
    }
  ],
  "title": "Oral glucocorticoids added to ILD‐modifying therapy in systemic sclerosis‐associated interstitial lung disease: a target trial emulation study from the EUSTAR database.",
  "title_text": "Oral glucocorticoids added to ILD‐modifying therapy in systemic sclerosis‐associated interstitial lung disease: a target trial emulation study from the EUSTAR database.",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:20:43Z",
  "url": "https://research.draconitic.com/paper/bd0fmvs2et607",
  "venue": "Arthritis Care and Research",
  "versions": []
}